GlassScriptPhysician profile
Michael Steven Payne
NPI 1467554808
$3,966.99
in general payments reported to CMS, 2019-2025
38 companies · $362 in 2025
The $362 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $445 · 2020: $513 · 2021: $555 · 2022: $594 · 2023: $798 · 2024: $700 · 2025: $362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,860.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,859.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $561.72 | 2021-2025 | |
| Glaxosmithkline, LLC. | $499.40 | 2019-2025 | Trelegy Ellipta |
| Pfizer INC. | $321.90 | 2019-2025 | |
| Amgen INC. | $272.62 | 2019-2025 | Repatha, Otezla, Otezla |
| Astrazeneca Pharmaceuticals LP | $261.71 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Janssen Pharmaceuticals, INC | $254.32 | 2019-2022 | |
| Lilly USA, LLC | $203.68 | 2020-2024 | Mounjaro, Jardiance, Emgality |
| Novo Nordisk INC | $198.88 | 2019-2024 | Rybelsus, Ozempic, Wegovy |
| Exact Sciences Corporation | $123.60 | 2023-2025 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $120.18 | 2022-2024 | |
| Phathom Pharmaceuticals, INC. | $106.56 | 2023-2025 | Voquezna |
| Antares Pharma, INC. | $100.79 | 2020-2025 | Xyosted |
| Takeda Pharmaceuticals U.S.A., INC. | $91.93 | 2019-2024 | Trintellix |
| Allergan, INC. | $74.85 | 2019-2020 | |
| Amarin Pharma, INC. | $70.65 | 2019-2020 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Payne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.